CN106421132A - Pollen pini composition with weight losing effect and preparation method thereof - Google Patents
Pollen pini composition with weight losing effect and preparation method thereof Download PDFInfo
- Publication number
- CN106421132A CN106421132A CN201610909099.6A CN201610909099A CN106421132A CN 106421132 A CN106421132 A CN 106421132A CN 201610909099 A CN201610909099 A CN 201610909099A CN 106421132 A CN106421132 A CN 106421132A
- Authority
- CN
- China
- Prior art keywords
- extract
- weight
- composition
- green tea
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 230000000694 effects Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 49
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 34
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 34
- 241000018646 Pinus brutia Species 0.000 claims abstract description 34
- 239000003814 drug Substances 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 20
- 244000269722 Thea sinensis Species 0.000 claims abstract description 10
- 235000009569 green tea Nutrition 0.000 claims abstract description 9
- 239000009609 fructus phyllanthi Substances 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000012467 final product Substances 0.000 claims description 15
- 229940094952 green tea extract Drugs 0.000 claims description 15
- 235000020688 green tea extract Nutrition 0.000 claims description 15
- 230000001413 cellular effect Effects 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 5
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- -1 hydroxyl isomaltulose Chemical compound 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 239000000686 essence Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 9
- 235000009200 high fat diet Nutrition 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 244000119298 Emblica officinalis Species 0.000 abstract 2
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 2
- 241000219780 Pueraria Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000700159 Rattus Species 0.000 description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 208000008589 Obesity Diseases 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 150000003626 triacylglycerols Chemical class 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 241001532589 Trimeresurus stejnegeri Species 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108700022737 rat Fat1 Proteins 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 229960001582 fenfluramine Drugs 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention discloses a pollen pini composition with the weight losing effect and a preparation method thereof. The composition is composed of effective components of broken wall pine pollen, extracts from pueraria, extracts from emblic leafflower fruits and extracts from green tea and auxiliary materials allowed in drugs and food, wherein the composition is prepared from, by weight, 300-600 parts of broken wall pine pollen, 50-120 parts of extracts from pueraria, 45-102 parts of extracts from emblic leafflower fruits and 100-420 parts of extracts from green tea. Animal experiments prove that the composition can quite remarkably lower the weight of a rat fed by high-fat diet, can remarkably lower the content of CHO and TG in serum and the content of fat in a body, and has the weight losing effect.
Description
Technical field
The present invention relates to a kind of have pine pollen composition of effect of weight reducing and preparation method thereof.
Background technology
Obesity (obesity) is a kind of chronic disease.Estimate that it is the appearance that the mankind face at present according to World Health Organization (WHO)
Easily ignored, but sickness rate is in a kind of disease steeply rising.In addition to the mankind, many house pets also can suffer from obesity.Suckling is moved
Thing storage (including people) hyperliposis, so that health is affected.
Obesity (obesity) is one group of common, ancient metabolism disease group.When human body feed heat is more than consumption of calorie
When, with storage as fat in internal, its amount exceedes normal physiological requirement to waste heat, and reaches and then develop into fertilizer during certain value
Fat disease.The 15%~18% of Normal Male Adults adipose tissue mass about percentage of liveweight, women accounts for 20%~25%.Increase with the age
Long, body fat proportion accordingly increases.Because body fat increase makes body weight be above standard body weight 20% or Body Mass Index [BMI=body weight
(Kg)/(height)2(m2)] it is referred to as obesity more than 24.As the no obvious cause of disease person of seeking can claim simple obesity;Have clearly
Cause of disease person is referred to as secondary obesity.
The traditional Chinese medical science thinks the cause of obesity, has four broad aspect:(1) natural endowment is relevant, and such as Chen Xiuyuan is said:" on the whole element is reported
Sheng ", i.e. inherited genetic factorss described in modern medicine;(2) addiction greasy and surfeit flavour, diet excess, nutritional labeling, drug on the market, that is,
《Huang di's Canon of Medicine》Described " fertile high official, the disease of fat meat and fine grain ";(3) drowsiness moves less, so that physical consumption is substantially reduced, and causes overnutrition,
Make fat fill cause fat in skin fat;(4) visceral dysfunction, stagnation of QI due to depression of the liver, insufficiency of the spleen mistake fortune, kidney deficiency gasification dereliction of duty, internal injury is long
Disease, the turbid interior life of expectorant, or it is subject to damp outward, so that phlegm-damp is accumulated fat in vivo.
Method for the treatment of is determined according to the cause of disease, the method for fat-reducing is when with invigorating the spleen and benefiting QI, dispelling phlegm and eliminating dampness, soothing the liver circulation of qi promoting, blood circulation promoting and blood stasis dispelling, tonification
Based on kidney qi, loosening bowel to relieve constipation, it is aided with promoting the circulation of qi helps digestion, lipid-loweringing expectorant, unclogs and readjusts the methods such as three Jiao, thus reconciling whole body function, plus
The unnecessary in vivo steatolysiss of speed, reach fat-reducing and disappear fat purpose.
The Western medicine drug of existing treatment obesity mainly has diethylpropion, Fenfluramine, thyroxin, adiposine
Deng, but possible using these medicines, drug side effect is big and easily produces drug resistance, there is potentially danger to the health of patient.
History with traditional Chinese medicine capable of reducing weight is of long standing and well established in China, and traditional Chinese medicine capable of reducing weight is according to the different body constitution of slimmer according to Chinese medical discrimination theory
Dialectical treat, suit the remedy to the case.Weight-losing Chinese patent medicine in the market is few, and existing medicine belongs to a bit cures the symptoms, not the disease, some
Using expensive composition, some interrupt because uncertain therapeutic efficacy is cut using in application process.Additionally, fat-reducing be one long
The process of phase, treatment by Chinese herbs obesity contains the catharsis medicine such as Radix Et Rhizoma Rhei, Folium Sennae mostly, long-term taking unsatisfactory curative effect, and for a long time
Take catharsis medicine and be easily caused function of intestinal canal imbalance.
Content of the invention
The purpose of the present invention is for problem of the prior art, provide a kind of pine pollen composition with effect of weight reducing and
Its preparation method, said composition determined curative effect, safe ready, Small side effects.
For achieving the above object, the present invention includes following technical scheme:
A kind of pine pollen composition with effect of weight reducing, it is to be extracted by breaking cellular wall Pollen Pini, Radix Puerariae extract, Fructus Phyllanthi
Thing and green tea extract are active component and allow the adjuvant composition using in medicine and food;Wherein, breaking cellular wall Pollen Pini,
300~600 weight portions;Radix Puerariae extract, 50~120 weight portions;Fructus Phyllanthi extract 45~102 weight portion;Green tea extract,
100~420 weight portions.
Pine pollen composition as above is it is preferable that described breaking cellular wall Pollen Pini, 390~500 weight portions;Radix Puerariae extracts
Thing, 70~100 weight portions;Fructus Phyllanthi extract 50~75 weight portion;Green tea extract, 200~300 weight portions.
Pine pollen composition as above is it is preferable that described breaking cellular wall Pollen Pini, 449 weight portions;Radix Puerariae extract, 82
Weight portion;Fructus Phyllanthi extract 67 weight portion;Green tea extract, 250 weight portions.
Pine pollen composition as above is it is preferable that described green tea is Folium Bambusae Folium Camelliae sinensis.
Pine pollen composition as above is it is preferable that the extracting method of described each extract is as follows:
Green tea extract:With water by 1 after Folium Camelliae sinensis are pulverized: the weight ratio of (15~90) mixes, extract at 40 DEG C~90 DEG C
0.5 hour~4 hours, filter, adjust pH value to be neutrality, concentrating under reduced pressure at 45 DEG C, lyophilization, obtain final product green tea extract;
Radix Puerariae extract:Take Radix Puerariae to add 4~water of 10 times of weight, boil extraction 2~3 times, each 0.5-3 hour, decompression
Water, lyophilization are evaporated off, obtain final product Radix Puerariae and take thing;
Fructus Phyllanthi extract:Take Fructus Phyllanthi, using the extraction of 45%-75% ethanol solution, 40-70 DEG C of extraction temperature, extraction
Time 1~4h, extracts 1~3 time, and feed liquid weight ratio is for 1: (15-30);Remove solvent, lyophilization under reduced pressure, obtain final product Fructus Phyllanthi and take
Thing.
Pine pollen composition as above is it is preferable that described allow the adjuvant using to be selected from sugarcane in medicine and food
Sugar, xylitol, Sorbitol, hydroxyl isomaltulose, isomaltulose, Mannitol, starch, dextrin, Microcrystalline Cellulose, Lactose,
One or more of hydroxypropyl methylcellulose, Semen Lini oil, Rhizoma amorphophalli powder, phospholipid, magnesium stearate.
On the other hand, the present invention provides the preparation method of pine pollen composition as above, and the method includes following step
Suddenly:
Described active component is uniformly mixed with the adjuvant of 1.5-6 times of weight, adds the ethanol solution of 75-95% to do moistening
Agent soft material, granulation of sieving;Wet granular at 35-75 DEG C, aeration-drying;Sieve granulate, obtains final product.
Have on the one hand, the present invention provides pine pollen composition as above to have the health food of effect of weight reducing in preparation
Or the application in medicine.
Apply it is preferable that described pine pollen composition is in terms of the total amount of active component as above, oral dose is
5-15g/ days.
The beneficial effects of the present invention is:The pine pollen composition of the present invention selects four kinds of medicine-food two-purpose compositions through Reasonable
5 form, and its lipid-loweringing loss of weight effect is apparently higher than single medicine.To high lipid food nutrition purposes, especially for feeding animals model test result indicate that, this
The pine pollen composition of invention can significantly reduce rat body weight in pole, and can significantly reduce CHO and TG and body fat in serum
Content.
Specific embodiment
The primary raw material of the present invention is Pollen Pini, Radix Puerariae, Fructus Phyllanthi and green tea.
Pollen Pini:Sweet in the mouth warm in nature, Return liver, spleen channel.There are astringing to arrest bleeding, eliminating dampness and astringing soreses.Modern study shows, Pollen Pini is inhaled
Can expand after water, make one satiety, food can be extended in gastric residence time, so that sugared absorbed speed is slowed down, from
And avoid unexpected Hyperglycemia, improve the degree of the resistance to sugar of human body;This external enwergy absorbs moisture softer stool, makes defecation smooth,
It is directly entered large intestine.
Radix Puerariae:Sweet in the mouth, pungent, cool in nature, attach to the lung and stomach meridians.There is resolving heat and reducing pathogenic fire, promoting the production of body fluid to quench thirst, nourishing YIN and invigorating YANG.To controlling
Treat and prevention chest and diaphragm dysphoria with smothery sensation, middle wind headache, hypertension, coronary heart disease, and blood fat reducing, blood sugar lowering, anticancer, fat-reducing all have special work(
Effect.
Fructus Phyllanthi:Sweet in the mouth, acid, puckery, cool in nature, return lung warp, stomach.There is the effect of relieving sore-throat by clearing away heat, nourishing the lung to arrest cough.For feeling
Emit heating, throat pain, cough, mouth thousand excessive thirst, otalgia, Vitamin C deficiency disease.
Green tea:Green tea has aid digestion and drops low-fat important effect, contributes to losing weight.Caffeine in green tea can improve
The secretory volume of gastric juice, can help digest.In addition, containing abundant catechin in green tea, contribute to slimming the abdomen.
Several specific embodiment of pine pollen composition with effect of weight reducing that the present invention exemplified below provides:
The preparation method of the extract used in following examples is as follows:
(1) preparation method of Radix Puerariae extract is as follows:
Take Radix Puerariae to add the water of 8 times amount, extract 2 times, 1.5 hours every time, remove water, lyophilization under reduced pressure, obtain final product Radix Puerariae and take
Thing.
(2) preparation method of Fructus Phyllanthi extract is as follows:
Take Fructus Phyllanthi, extracted using 55% ethanol solution, 55 DEG C of extraction temperature, extraction time 2h, extract 2 times, feed liquid matter
Amount ratio is 1: 20;Remove solvent, lyophilization under reduced pressure, obtain final product Fructus Phyllanthi and take thing.
(3) preparation method of green tea extract is as follows:
Green tea extract:Mix by 1: 20 weight ratio with water after Folium Camelliae sinensis are pulverized, extract 2 hours at 60 DEG C, filter, adjust pH
It is worth for 7, concentrating under reduced pressure at 45 DEG C, lyophilization, obtain final product green tea extract.
Embodiment 1:There is the pine pollen composition () of effect of weight reducing
Breaking cellular wall Pollen Pini, 449 weight portions;Radix Puerariae extract, 82 weight portions;Fructus Phyllanthi extract 67 weight portion;Trimeresurus stejnegeri
Tea extract, 250 weight portions.Each component is uniformly mixed, adds 95% ethanol solution to do wetting agent soft material, cross sieve series
Grain;Wet granular at 55 DEG C, aeration-drying;Sieve granulate, obtains final product.
Embodiment 2:There is the pine pollen composition (two) of effect of weight reducing
Breaking cellular wall Pollen Pini, 495 weight portions;Radix Puerariae extract, 75 weight portions;Fructus Phyllanthi extract, 55 weight portions;Trimeresurus stejnegeri
Tea extract, 223 weight portions.Each component is uniformly mixed, adds 95% ethanol solution to do wetting agent soft material, cross sieve series
Grain;Wet granular at 55 DEG C, aeration-drying;Sieve granulate, obtains final product.
Embodiment 3:There is the pine pollen composition (three) of effect of weight reducing
Breaking cellular wall Pollen Pini, 415 weight portions;Radix Puerariae extract, 90 weight portions;Fructus Phyllanthi extract 70 weight portion;Trimeresurus stejnegeri
Tea extract, 273 weight portions.Each component is uniformly mixed, adds 95% ethanol solution to do wetting agent soft material, cross sieve series
Grain;Wet granular at 55 DEG C, aeration-drying;Sieve granulate, obtains final product.
Comparative example 1
Breaking cellular wall Pollen Pini, 449 weight portions;Radix Puerariae extract, 82 weight portions;Fructus Phyllanthi extract 67 weight portion.By each group
Divide and uniformly mix, add 95% ethanol solution to do wetting agent soft material, granulation of sieving;Wet granular at 55 DEG C, aeration-drying;
Sieve granulate, obtains final product.
Experimental example 1 pine pollen composition high lipid food feeds the experiment of rat improvement result
One. test principle:
This test adopts high lipid food to feed rat, inquires into the improvement work that each Weight reducing compound feeds rat to high lipid food
With.
Two. test material:
Laboratory animal:Male SD rat, purchased from Beijing company limited of dimension tonneau China, quality certification number:SCXK (capital) 2014-
0001, raise in China Medical Sciences Academy Medical Plants Institute SPF level Animal House, credit number:SYXK (capital) 2013-
0023,22 ± 2 DEG C of room temperature, relative humidity 60%RH.
High lipid food:Containing 10% Adeps Sus domestica, 10% yolk powder and 80% normal feedstuff, limited by magnificent Fukang biotechnology share
Company provides.
Test sample:The pine pollen composition of embodiment 1-3 preparation, the compositionss of comparative example 1 preparation, breaking cellular wall Pollen Pini, bamboo
Leaf Folium Camelliae sinensis extract.
People takes daily standard dose (middle dosage):The pine pollen composition 10.3g of embodiment 1-3 preparation, comparative example 1 is made
Standby compositionss 10.3g.
Make light of one's life by commiting suicide the fat ball that disappears, Beijing Tongrentang Technology Development Co.ltd. Pharmaceutical Factory, batch number:14030049.
Reagent:Serum triglycerides (TG), cholesterol (CHO), low-density lipoprotein cholesterol (LDL) and high density lipoprotein level
White cholesterol (HDL) test kit, by Beijing, Zhongsheng Beikong Biological Science & Technology Co., Ltd. provides.
Three. test method:
Animal packet:Using male SD rat, every group 10.Experiment sets 12 groups:Normal control, model comparison, enforcement
Example 1-3 pine pollen composition low dosage (0.325g/kg), middle dosage (0.65g/kg), high dose (1.3g/kg), 1 group of comparative example
Compound low dosage (0.325g/kg), middle dosage (0.65g/kg), high dose (1.3g/kg) (be respectively equivalent to people's consumption 2.5,
5 and 10 times), breaking cellular wall Pollen Pini group (1.3g/kg), Trimeresurus stejnegeri tea extract group (0.325g/kg), (making light of one's life by commiting suicide, it is fat to disappear for positive control
Ball, 750mg/kg) (being equivalent to 5 times of people's consumption).
Test method:
Feed by giving high lipid food after body weight packet, except normal and model group, start gastric infusion one month.
1. weigh weekly twice, measure food ration.
2. after off-test, weigh body fat (testis and perirenal fat pad).
Lipids detection:Measure serum oil three esters (TG), cholesterol (CHO), low-density lipoprotein cholesterol (LDL) and highly dense
Degree lipoprotein cholesterol (HDL) level.
Four. statistical method
Measurement data data is represented with meansigma methodss ± standard error (mean ± standard error), comparison in difference between each group
Using t inspection, completed by EXCEL statistical software.P < 0.05 is that there were significant differences, and p < 0.01 is to have pole significant difference.
Five. result of the test:
(1) diet products feed the impact of rat outward appearance to high lipid food:
Observe weekly the behavior state of every rat, emotional response, active degree, diet, skin and hair, sleep, stool,
Compare with Normal group, high lipid food is fed rat and shown no obvious abnormalities.
(2) impact to high fat diet rat body weight for the diet products:
The results are shown in Table 1, compare with normal group, after 2 weeks, model group rats body weight increase starts to carry feeding rats high lipid food
Height, is compared with model group, and embodiment 1,2,3 high dose group body weight all occurs pole to significantly reduce, the basic, normal, high dosage group of embodiment 1
Surrounding reduces body weight 6.60% (p < 0.01), 6.40% (p < 0.05), 9.40% (p < 0.01) respectively.
The impact (g, X ± SD) (n=10) to rat body weight for table 1 diet products
Compared with normal group,##P < 0.01,#P < 0.05
Compare with model control group,*P < 0.05, has significant difference,*P < 0.01, has pole significant difference
(3) impact to high fat diet rat food ration for the diet products:
Compare with model group, embodiment 1-3 rat has reduced in the food ration of 3w, but 4w gradually recovers.
The impact (g, X ± SD) (n=10) to rat food ration for table 2 diet products
(4) impact to high fat diet rat fat and fat mass for the diet products:
The results are shown in Table 3, feeding rats high lipid food, after 4 weeks, is compared with normal group, TG (glycerol in model group rats serum
Three esters) content increase.Compare with model group, embodiment 1,2,3 high dose group change of serum C HO (T-CHOL), TG content are all notable
Reduce, wherein, 1 group of embodiment reduces 13.01% (p < 0.05) change of serum C HO content and 23.64% (p < 0.05) serum TG
Content.
Compare with normal group, model group rats fat content dramatically increases.Compare with model group, the high agent of embodiment 1,2,3
Amount group fat mass all significantly reduces, and wherein, embodiment 1 high dose can substantially reduce 22.5% fat mass (p < 0.05).
The effect (mmol/L, X ± SD) (n=10) to high fat diet rat fat and fat mass for table 3 diet products
Compare with Normal group,##P < 0.01, has pole significant difference to compare with model control group,*P < 0.05, has
Significant difference,*P < 0.01, has pole significant difference
6th, conclusion
Embodiment 1,2,3 high dose group can significantly reduce CHO and TG and body fat content in serum.Result above table
Bright embodiment 1-3 pine pollen composition has regulation improvement result to high fat diet rat hyperlipidemia and fat content, has and subtracts
Fertile effect.
Claims (9)
1. a kind of pine pollen composition with effect of weight reducing it is characterised in that its be by breaking cellular wall Pollen Pini, Radix Puerariae extract,
Fructus Phyllanthi extract and green tea extract are active component and allow the adjuvant composition using in medicine and food;Wherein,
Breaking cellular wall Pollen Pini, 300~600 weight portions;Radix Puerariae extract, 50~120 weight portions;Fructus Phyllanthi extract 45~102 weight portion;
Green tea extract, 100~420 weight portions.
2. pine pollen composition as claimed in claim 1 is it is characterised in that described breaking cellular wall Pollen Pini, 390~500 weight portions;
Radix Puerariae extract, 70~100 weight portions;Fructus Phyllanthi extract 50~75 weight portion;Green tea extract, 200~300 weight portions.
3. pine pollen composition as claimed in claim 1 is it is characterised in that described breaking cellular wall Pollen Pini, 449 weight portions;Radix Puerariae
Extract, 82 weight portions;Fructus Phyllanthi extract 67 weight portion;Green tea extract, 250 weight portions.
4. pine pollen composition as claimed in claim 1 is it is characterised in that described green tea is Folium Bambusae Folium Camelliae sinensis.
5. pine pollen composition as claimed in claim 1 is it is characterised in that the extracting method of described each extract is as follows:
Green tea extract:With water by 1 after Folium Camelliae sinensis are pulverized: the weight ratio of (15~90) mixes, little in 40 DEG C~90 DEG C extractions 0.5
When~4 hours, filter, adjust pH value to be neutrality, concentrating under reduced pressure at 45 DEG C, lyophilization, obtain final product green tea extract;
Radix Puerariae extract:Take Radix Puerariae to add 4~water of 10 times of weight, boil extraction 2~3 times, each 0.5-3 hour, remove under reduced pressure
Water, lyophilization, obtain final product Radix Puerariae and take thing;
Fructus Phyllanthi extract:Take Fructus Phyllanthi, using the extraction of 45%-75% ethanol solution, 40-70 DEG C of extraction temperature, extraction time 1
~4h, extracts 1~3 time, and feed liquid weight ratio is for 1: (15-30);Remove solvent, lyophilization under reduced pressure, obtain final product Fructus Phyllanthi and take thing.
6. the pine pollen composition according to any one of claim 1-5 it is characterised in that described in medicine and food
The adjuvant using is allowed to be selected from sucrose, xylitol, Sorbitol, hydroxyl isomaltulose, isomaltulose, Mannitol, starch, paste
One of essence, Microcrystalline Cellulose, Lactose, hydroxypropyl methylcellulose, Semen Lini oil, Rhizoma amorphophalli powder, phospholipid, magnesium stearate or several
Kind.
7. the preparation method of the pine pollen composition as any one of claim 1-6 is it is characterised in that the method includes
Following steps:
Described active component is uniformly mixed with the adjuvant of 1.5-6 times of weight, adds the ethanol solution of 75-95% to do wetting agent system
Soft material, granulation of sieving;Wet granular at 35-75 DEG C, aeration-drying;Sieve granulate, obtains final product.
8. the pine pollen composition described in any one of claim 1-6 is in health food or the medicine that preparation has effect of weight reducing
Application.
9. as claimed in claim 8 application it is characterised in that described pine pollen composition is in terms of the total amount of active component,
Oral dose is 5-15g/ days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610909099.6A CN106421132A (en) | 2016-10-18 | 2016-10-18 | Pollen pini composition with weight losing effect and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610909099.6A CN106421132A (en) | 2016-10-18 | 2016-10-18 | Pollen pini composition with weight losing effect and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106421132A true CN106421132A (en) | 2017-02-22 |
Family
ID=58175435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610909099.6A Pending CN106421132A (en) | 2016-10-18 | 2016-10-18 | Pollen pini composition with weight losing effect and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106421132A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110089596A (en) * | 2018-01-29 | 2019-08-06 | 周凯亮 | A kind of health alternative tea |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105613835A (en) * | 2016-01-27 | 2016-06-01 | 刘翰锦 | Preparation method of natural pine pollen Liupu tea |
-
2016
- 2016-10-18 CN CN201610909099.6A patent/CN106421132A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105613835A (en) * | 2016-01-27 | 2016-06-01 | 刘翰锦 | Preparation method of natural pine pollen Liupu tea |
Non-Patent Citations (3)
Title |
---|
潘玲等: "成年营养性肥胖大鼠模型", 《中药药理与临床》 * |
王磊等: "幼年雄性SD大鼠营养性肥胖模型的建立", 《药物研究》 * |
陈巾宇等: "肥胖模型大鼠锌营养状态指标的检测及意义", 《中国实验诊断学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110089596A (en) * | 2018-01-29 | 2019-08-06 | 周凯亮 | A kind of health alternative tea |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940620B (en) | Medicinal composition for treating diabetes mellitus and application thereof | |
CN104367879A (en) | Pharmaceutical composition for chickens' internal lesion caused by overexertion and preparation method of pharmaceutical composition | |
CN107362213B (en) | Composition with bowel relaxing function and preparation method thereof | |
CN103203008A (en) | Pharmaceutical composition for sobering up and preparation method thereof | |
CN108404062A (en) | Treat the Chinese medicine composition and its preparation method and application of hyperlipidemia | |
CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
CN104905267A (en) | Semen cassiae health oral liquid capable of decreasing blood lipid and preparation method thereof | |
CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
CN106362020A (en) | Pine pollen composition with defaecation improving effect and preparation method of pine pollen | |
CN106177432A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati | |
CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
CN106173605A (en) | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii | |
CN106176952A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja and Folium Ilicis | |
CN104587429A (en) | Ginger juice and honey impregnated American ginseng preparation and preparation method thereof | |
CN106110072A (en) | A kind of Herba Lophatheri compositions with effect of weight reducing and preparation method thereof | |
CN104001045A (en) | Drug for treating dog pneumonia and preparation method thereof | |
CN106421132A (en) | Pollen pini composition with weight losing effect and preparation method thereof | |
CN106177054A (en) | A kind of Hyperglycemic health care compositions comprising Cortex Mori and Pericarpium Citri Reticulatae | |
CN104825821A (en) | Medicine for treating diabetes and preparation method thereof | |
TWI728304B (en) | Yin nourishing and kidney tonifying composition and its preparation method and application | |
CN104491718B (en) | Medicine for treating liver-depression and phlegm-stasis type mammary gland hyperplasia and preparation method | |
CN115089661A (en) | Application of ginseng composition for assisting in regulating endocrine metabolism and resisting and preventing cancer | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN112402569A (en) | Anti-fatigue health product and preparation method thereof | |
CN106177476A (en) | A kind of Hyperglycemic health care compositions comprising Herba Dendrobii and Pericarpium Citri Reticulatae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180309 Address after: 102206 Beijing city Changping District Science Park Road 10 Huilongguan Hospital No. 1 building 4 layer Applicant after: Guozhen Health Science and Technology (Beijing) Co., Ltd. Address before: No. 1, hospital No. 10, Zhongguancun Life Science Park Road, Zhongguancun, Changping District, Beijing Applicant before: New Age Health Industry(Group) Co., Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |